Association of serum magnesium levels and calcimimetic use: fractures and cardiovascular events in Japanese haemodialysis patients

Key Points

• Higher serum magnesium levels may reduce the risk of fractures, highlighting their protective role in bone health.
• Calcimimetic use shows a potential link to lower cardiovascular events among patients undergoing haemodialysis.
• Observational analysis of Japanese haemodialysis patients utilizing serum magnesium and calcimimetics informs future treatment strategies.
• Findings may enable enhanced management protocols for preventing fractures and cardiovascular complications in this population.